The first GWAS of IgAV/HSP revealed that the HLA class II region (mainly HLA-DRB1*01 allele) in the European population is associated with the risk for IgAV/HSP, although this finding did not reach genome-wide significance (42). This evidence concerns the gene HLA-DRB1 and hereditary spastic paraplegia.